LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES
hemorrhagic moyamoya disease experienced rebleeding
regardless of the treatment modalities. The prognosis of
rebleeding in patients with hemorrhagic moyamoya disease is
extremely poor, and several authors have come to the conclusion
that there is still no clear evidence that revascularization surgery
significantly prevents rebleeding in these patients.7,8,9 Factors
related to rebleeding and poorer outcome are sex (with women
being more susceptible), massive intracranial hemorrhage and
early recurrence. We believe that the risk of rebleeding in our
patient was high, given that she was a female, with a massive
intracranial hemorrhage and with a rapidly growing cerebral
aneurysm associated with spontaneous MCA occlusion. A
revascularization procedure was not a promising option for
treatment and it was not considered.
A direct surgical approach has been thought to be necessary
in treating aneurysms in patients with moyamoya disease and
associated subarachnoid hemorrhage.10 However, it has been
shown that compression of the perforating vessels around
aneurysms of the parent artery during surgical clipping can
induce circulatory compromise leading to postoperative
hemiplegia or severe brain edema.10 Furthermore, excessive
hypotension and decreased PCO2 in the blood during surgery
must be avoided, because patients with moyamoya disease are
particularly susceptible to cerebral ischemia. In a review of 111
cases of aneurysms associated with moyamoya disease,
Kawaguchi et al1 have suggested that direct surgery is not
recommended for aneurysms found in the basal ganglia or in the
collateral vessels. In our case, the fragility of adjacent vessels
and the danger of damaging important collateral vessels made us
consider an endovascular approach.
Guglielmi electrically detachable coils (GDC) have been used
in the treatment of major artery aneurysms associated with
moyamoya disease.11 There has been a case report of
endovascular treatment using platinum coils of a peripheral
artery aneurysm associated with moyamoya disease.2
Endovascular treatment of a small aneurysm of the right anterior
choroidal artery was performed with preservation of the parent
artery. We considered this a good treatment option, but we were
unable to place our microcatheter far enough into the feeding
artery to safely deploy a coil.
Endovascular embolization of rapidly growing aneurysms
arising from moyamoya-type vessels using the mixture of NBCA
and lipiodol has, to our knowledge, not been reported. We used
this approach because the microcatheter could only be placed in
the proximal segment of the parent vessel and not into the
aneurysm. We recognize the risk of NBCA either refluxing into
the proximal MCA or occluding collateral channels but, given
the fact that the patient was already hemiplegic on the left side,
we believed that little or no further clinical deterioration could be
caused with a slow and careful injection of a small volume of
liquid embolizing agent. We believed that urgent treatment of the
unstable aneurysm was necessary to prevent further bleeding.
We do not recommend this type of treatment as a routine
practice in aneurysms arising from moyamoya-type vessels. This
option can be considered when the aneurysm can not be directly
accessed for coil treatment and the likelihood of causing further
neurologic injury is low.
REFERENCES
1. Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K.
Characteristics of intracranial aneurysms associated with
moyamoya disease. A review of 111 cases. Acta Neurochir
(Wien) 1996;138(11):1287-1294.
2. Sugiura Y, Matsuzawa Y. Endovascular treatment using platinum
coil of a peripheral artery aneurysm associated with moyamoya
disease: case report. No Shinkei Geka 1998;26(1):73-77.
3. Maekawa M, Nemoto S, Awaya S, Teramoto A. Moyamoya disease
with intraventricular hemorrhage due to rupture of lateral
posterior choroidal artery aneurysm: case report. No Shinkei
Geka 1999;27(11):1047-1051.
4. Kidoguchi J, Chiba M, Murakami T, et al. A case of systemic lupus
erythematosus associated with an aneurysm of the lenticulostriate
artery. No Shinkei Geka 1987;15(11):1221-1225.
5. Shibuya P, Hayashi N. A case of posterior cerebral artery aneurysm
associated with idiopathic bilateral internal carotid artery
occlusion: case report. Surg Neurol 1999;52:617-622.
6. Takahashi M, Fujimoto T, Suzuki R, et al. A case of spontaneous
middle cerebral artery occlusion associated with a cerebral
aneurysm angiographically disappearing after STA-MCA
anastomosis. No Shinkei Geka 1997;25(8):727-732.
7. Ikezaki K, Fukui M, Inamura T, et al. The current status of the
treatment for hemorrhagic type moyamoya disease based on a
1995 nationwide survey in Japan. Clin Neurol Neurosurg
1997;99(S2):183-186.
8. Choi JU, Kim DS, Kim EY, Lee KC. Natural history of moyamoya
disease: comparison of activity of daily living in surgery and
nonsurgery groups. Clin Neurol Neurosurg 1997;99(S2):11-18.
9. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y. Clinical course,
surgical management, and long-term outcome of moyamoya
patients with rebleeding after an episode of intracerebral
hemorrhage. An extensive follow-up study. Stroke 1999;30:2272-
2276.
10. Kodama N, Sato M, Sasaki T. Treatment of ruptured cerebral
aneurysm in moyamoya disease. Surg Neurol 1996;46:62-66.
11. Massoud TF, Guglielmi G, Viñuela F, Duckwiler GR. Saccular
aneurysms in Moyamoya disease: endovascular treatment using
electrically detachable coils. Surg Neurol 1994;41:462-467.
Volume 28, No. 3 – August 2001
259